Back to search
Agitation in Patients With Dementia of the Alzheimer's Type
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Agitation in Patients With Dementia of the Alzheimer's Type trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Agitation in Patients With Dementia of the Alzheimer's Type trials you may qualify forThis is a multicenter, randomized, double-blind, placebo-controlled, flexible-dose study of the efficacy, safety, and tolerability of ITI-1284 in patients with…
To evaluate the efficacy and safety of ONO-2020 in patients with agitation associated with Alzheimer's Disease dementia in Japan.
This is a randomized, double-blinded, placebo-controlled, crossover trial that aims to 1) determine the efficacy of THC-free cannabidiol (CBD oil) in reducing t…
This study tests a medication called dronabinol in people with Alzheimer's disease. First, participants go through up to 4 weeks of screening. Then, over 2 week…
The primary objective of this open-label extension trial is to evaluate the long-term safety of AXS-05 for the treatment of Alzheimer's disease agitation in sub…